SCHEMBL7849281

SCHEMBL7849281

CC(C)(O)[C@@H](CCc1cccc(Cl)c1Cl)NC(=O)c1c[nH]cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADA P00813 1/20 0.39
CTSG P08311 2/20 0.33
CMA1 P23946 2/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
TAS1R2 Q8TE23 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
P2RX7 Q99572 3/20 0.32
TRPV1 Q8NER1 1/20 0.32
CNR2 P34972 1/20 0.32
PRSS1 P07477 1/20 0.32
CTRB1 P17538 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
ROCK2 O75116 1/20 0.31
ROCK1 Q13464 1/20 0.31
PANK3 Q9H999 1/20 0.31
SLC6A4 P31645 1/20 0.31
ENPP2 Q13822 1/20 0.31
MME P08473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7449449 0.83 ADA (0.47) ADACTSGCMA1TAS1R3TAS1R1
SCHEMBL7450779 0.76 CTSG (0.37) ADACTSGCMA1
SCHEMBL7452035 0.74 SLC6A2 (0.40) ADAMEN1KMT2AP2RX7SLC6A4
SCHEMBL7448880 0.68 PTGER1 (0.37) SLC6A4
SCHEMBL7453035 0.67 NPC1 (0.32) ADAMEN1KMT2AP2RX7
SCHEMBL7449045 0.67 ADA (0.38) ADA
SCHEMBL7452225 0.67 ADA (0.38) ADA
SCHEMBL7452233 0.67 RAB9A (0.33) ADAMEN1KMT2ATAAR1ANO1
SCHEMBL7849285 0.67 ADA (0.47) ADACTSGCMA1TRPV1TAAR1
SCHEMBL7837015 0.67 ADA (0.47) ADAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1161429-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-12-12 EP disclosed
WO-2000055155-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-09-21 WO disclosed